how to say retatrutide Retatrutide for weight loss: Study

Description

A 2024 meta-analysis found GLP-1 receptor agonists helped lower BMI, waist circumference, triglycerides, and total testosterone in women with PCOS living with obesity

Instead of faxing a form, providers (or pharmacists) click a button in the EHR or pharmacy system that triggers a digital PA transaction

Keywords: Glucagon, Glucagon-like peptide-1 receptor agonist, Glucose-dependent insulinotropic peptide receptor, Incretin, Obesity, Type 2 diabetes mellitus Introduction Type 2 diabetes mellitus (T2DM) and obesity are becoming more and more common worldwide, a phenomenon which greatly increases morbidity and mortality from conditions like cancer and heart disease, among many others [1]

1 Dual agonism of GIP and GLP-1 receptors is a promising new approach currently in clinical development for the treatment of diabetes, obesity, and associated complications [1] The incretin effect defines the main physiological role of GIP and GLP-1 GIP and GLP-1 increase insulin secretion following nutrient-induced secretion from the gut (incretin effect): There is a stronger insulin secretion response to oral compared to 'isoglycemic' intravenous glucose administration due to secretion and action of incretin hormones

Ro emphasizes convenient access to clinicians and prescriptions, focusing primarily on medication management and medical oversight, with less emphasis on long-term habit support